BioInvent at a glance

As of June 30, 2025

4
Programs in clinical development
10+
Licensing, supply and collaboration agreements
122
Employees (full time equivalent)
797.5
SEKm in liquid funds etc

Jefferies Global Healthcare Conference, New York

Corporate presentation
Thursday, June 5 at 2:35-3:05 pm EDT

Link to webcast

 

Investor Relations contact

BioInvent strives to provide the financial markets with accurate, consistent and relevant information about the company on a regular basis. In the first instance, IR-related issues should be addressed to the Senior Director Investor Relations.

Cecilia Hofvander

Senior Director Investor Relations

046-286 85 50